L. Choix-de, 40 PARTIE II : la procréation médicalement assistée 1. Cadre légal de l, p.42

V. Fécondation-in, FIV avec micro-injection (ICSI), p.75

.. Mode-d-'emploi-général, Les tests d'ovulation disponibles en officine, p.85

.. Analyse-des-résultats-par-items, Réponses relatives à l'item « Vous et l'officine, p.102

.. La-formation-du-pharmacien, 123 3.1 Formation continue, FCC), p.123

J. Zorn and M. Et-savale, Stérilité du couple, 2005.

J. Lansac and F. Et-guérif, AMP: l'assistance médicale à la procréation en pratique

F. Olivennes, A. Hazout, and R. Et-frydman, Assistance médicale à la procréation

N. Vervloesem, Natisens: site d'information sur la procréation médicalement assistée, 2012.

G. R. Michael, D. J. Hull, and . Cahill, Female infertility, Endocrinology and Metabolism Clinics of North America, pp.851-876, 1998.

M. Jin, Y. Yu, and H. Et-huang, An update on primary ovarian insufficiency, Science China Life Sciences, vol.89, issue.8, pp.677-686, 2012.
DOI : 10.1016/j.fertnstert.2007.02.032

M. Gruszka, J. Wilczy?ski, and D. Et-nowakowska, Prevalence of uterine malformations and their impact on fertility, Ginekol. Pol, vol.83, pp.517-521, 2012.

J. Koch, K. Rowan, L. Rombauts, A. Yazdani, M. Chapman et al., Endometriosis and Infertility - a consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence), Australian and New Zealand Journal of Obstetrics and Gynaecology, 2012.
DOI : 10.1016/j.ejogrb.2009.09.007

T. Hargreave and C. Ghosh, Male fertility disorders, Endocrinology and Metabolism Clinics of North America, pp.765-782, 1998.

J. Paavonen and W. Et-eggert-kruse, Chlamydia trachomatis: impact on human reproduction, Human Reproduction Update, vol.5, issue.5, pp.433-447, 1999.
DOI : 10.1093/humupd/5.5.433

J. Berthiller and A. Et-sasco, Smoking (active or passive) in relation to fertility, medically assisted procreation and pregnancy, J Gynecol Obstet Biol Reprod, vol.34, issue.1, pp.3-47, 2005.

S. Sépaniak, T. Forges, and P. Et-monnier-barbarino, Tabac et??fertilit?? chez??la??femme et??l'homme, Gyn??cologie Obst??trique & Fertilit??, vol.34, issue.10, pp.945-949, 2006.
DOI : 10.1016/j.gyobfe.2006.06.018

J. De-mouzon and J. Et-belaisch-allart, Consequences on women's fecundity and on assisted reproductive technology, J Gynecol Obstet Biol Reprod, vol.34, issue.1, pp.3-112, 2005.

D. E. Stewart, E. Robinson, D. S. Goldbloom, and C. Et-wright, Infertility and eating disorders, American Journal of Obstetrics and Gynecology, vol.163, issue.4, pp.1196-1199, 1990.
DOI : 10.1016/0002-9378(90)90688-4

N. Mmbaga and J. Et-luk, The impact of preconceptual diet on the outcome of reproductive treatments, Current Opinion in Obstetrics and Gynecology, vol.24, issue.3, pp.127-131, 2012.
DOI : 10.1097/GCO.0b013e3283530524

V. Rusz, V. Pilatz, F. Wagenlehner, T. Linn, T. Diemer et al., Influence of urogenital infections and inflammation on semen quality and male fertility, World Journal of Urology, vol.61, issue.2, pp.23-30, 2012.
DOI : 10.1016/S0015-0282(16)56765-X

M. C. Micu, R. Micu, and M. Et-ostensen, Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies, Arthritis Care & Research, vol.41, issue.9, pp.1334-1338, 2011.
DOI : 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8

J. F. Skomsvoll, E. Rødevand, H. S. Koksvik, K. A. Salvesen, V. Von-düring et al., Reversible infertility from nonsteroidal anti-inflammatory drugs], Tidsskr. Nor. Laegeforen, vol.125, pp.1476-1478, 2005.

J. D. Fish, Fertility preservation for adolescent women with cancer, Adolesc Med State Art Rev, vol.23, pp.111-122, 2012.

M. Lappi and A. Et-borini, Fertility Preservation in Women After the Cancer, Current Pharmaceutical Design, vol.18, issue.3, pp.293-302, 2012.
DOI : 10.2174/138161212799040420

S. Droupy, Mise au point : médicaments et sexualité, 2002.

. Fivfrance, Portail d'information sur l'assistance médicale à la procréation

J. Guibert, La revue du praticien médecine générale, Suspicion d'infertilité, pp.445-453, 2007.

(. P. Pharmacorama, F. Gonadotrophines, . Lh, and . Prolactine, Hormones hypophysaires http://www.pharmacorama.com/Rubriques/Output/Hormones_antehypophysairesa3_1.ph p [29] Pharmacorama (P. Allain) (page consultée le 11 novembre 2011). Estrogènes, Estrogenesa2.php [30] Pharmacorama (P. Allain) (page consultée le 11 novembre 2011). Progestérone et Progestatifs

B. Leininger, Les marqueurs de la fertilité, 2010.

R. Frydman, Assistance médicale à la procréation, 3e, Presses Universitaires de France -PUF, 2004.

A. Jungwirth, A. Giwercman, H. Tournaye, T. Diemer, Z. Kopa et al., European Association of Urology Guidelines on Male Infertility: The 2012 Update, European Urology, vol.62, issue.2, pp.324-332, 2012.
DOI : 10.1016/j.eururo.2012.04.048

. Agence-de-la-biomédecine, Assistance médicale à la procréation, 2012.

P. Merviel, Assistance médicale à la procréation, Editions Eska, 2006.

B. Esper and C. , AMP : une activité strictement encadrée Adsp (en ligne), 2011.

. Légifrance, Code de la santé publique, pp.17-2012

A. Publique-hp, L'assistance médicale à la procréation. Doin, 2003.

P. Kumar, S. F. Sait, A. Sharma, and M. Et-kumar, Ovarian hyperstimulation syndrome, Journal of Human Reproductive Sciences, vol.4, issue.2, pp.70-75, 2011.
DOI : 10.4103/0974-1208.86080

W. Ombelet, G. Martens, D. Sutter, P. Gerris, J. Bosmans et al., Perinatal outcome of 12 021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study, Human Reproduction, vol.21, issue.4, pp.1025-1032, 2006.
DOI : 10.1093/humrep/12.11.2408

J. L. Shaw, S. K. Dey, H. O. Critchley, and A. W. Et-horne, Current knowledge of the aetiology of human tubal ectopic pregnancy, Human Reproduction Update, vol.137, issue.3, pp.432-444, 2010.
DOI : 10.1023/B:BEBM.0000031559.93848.07

J. Bouyer, J. Coste, T. Shojaei, J. Pouly, H. Fernandez et al., Risk Factors for Ectopic Pregnancy: A Comprehensive Analysis Based on a Large Case-Control, Population-based Study in France, American Journal of Epidemiology, vol.157, issue.3, pp.185-194, 2003.
DOI : 10.1093/aje/kwf190

URL : https://hal.archives-ouvertes.fr/inserm-00086499

M. Hippeläinen, Infertility and risk of cancer, Duodecim, vol.128, pp.851-857, 2012.

E. S. Jungheim and A. O. Et-odibo, Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents, Fertility and Sterility, vol.94, issue.7, pp.2659-2664, 2010.
DOI : 10.1016/j.fertnstert.2010.03.077

P. Dorosz, D. V. Durand, and C. L. Et-jeunne, Guide pratique des médicaments 2012, p.31, 2011.

J. E. Chavarro, J. W. Rich-edwards, B. A. Rosner, and W. C. Et-willett, Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility, Fertility and Sterility, vol.89, issue.3, pp.668-676, 2008.
DOI : 10.1016/j.fertnstert.2007.03.089

A. E. Czeizel, J. Métneki, and I. Et-dudás, The effect of preconceptional multivitamin supplementation on fertility, Int J Vitam Nutr Res, vol.66, pp.55-58, 1996.

K. Tremellen, G. Miari, D. Froiland, and J. Et-thompson, A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment, The Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.133, issue.3, pp.216-221, 2007.
DOI : 10.1016/j.urology.2003.07.018

A. Agarwal, S. Gupta, and R. Et-sharma, Role of oxidative stress in female reproduction, Reproductive Biology and Endocrinology, vol.3, issue.1, p.28, 2005.
DOI : 10.1186/1477-7827-3-28

E. H. Ruder, T. J. Hartman, J. Blumberg, and M. B. Et-goldman, Oxidative stress and antioxidants: exposure and impact on female fertility, Human Reproduction Update, vol.14, issue.4, pp.345-357, 2008.
DOI : 10.1093/humupd/dmn011

W. Y. Wong, H. M. Merkus, C. M. Thomas, R. Menkveld, G. A. Zielhuis et al., Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial, Fertility and Sterility, vol.77, issue.3, pp.491-498, 2002.
DOI : 10.1016/S0015-0282(01)03229-0

C. Poncelet, S. Et, and C. , Physiologie, pathologie et thérapie de la reproduction chez l'humain, 2011.
DOI : 10.1007/978-2-8178-0061-5

M. K. Moslemi and S. Et-tavanbakhsh, Selenium&ndash;vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate, International Journal of General Medicine, vol.4, pp.99-104, 2011.
DOI : 10.2147/IJGM.S16275

A. Agarwal and L. H. Et-sekhon, Oxidative stress and antioxidants for idiopathic oligoasthenoteratospermia: Is it justified?, Indian Journal of Urology, vol.27, issue.1, pp.74-85, 2011.
DOI : 10.4103/0970-1591.78437

M. Roqueta-rivera, C. K. Stroud, W. M. Haschek, S. J. Akare, M. Segre et al., Docosahexaenoic acid supplementation fully restores fertility and spermatogenesis in male delta-6 desaturase-null mice, Journal of Lipid Research, vol.34, issue.2, pp.360-367, 2010.
DOI : 10.1186/1477-7827-6-32

. Pharméa, Envie d'un bébé? Tout savoir pour optimiser vos chances de grossesse, pp.1-17, 2011.

L. Inpes, pdf [67] Inpes, Livret d'accompagnement destiné aux professionnels de santé (en ligne), 2012, www.inpes.sante.fr/cfesbases/catalogue/pdf/1060.pdf [68] HAS, Comment mieux informer les femmes enceintes (en ligne) Projet de grossesse : informations, messages de prévention, examens à proposer, ] CNGOF, La prise en charge du couple infertile, extrait des mises à jour en Gynécologie et ObstétriqueSe former pour mieux prendre en charge la fertilité à l'officine". Impact pharmacien, pp.14-15, 1059.

W. Pharma, Formation continue conventionnelle

. Ameli, Votre formation continue conventionnelle. http://www.ameli.fr/professionnels-de-sante/pharmaciens/vous-former-vousinformer/votre-formation-continue-conventionnelle/les-themes-et-actions-de-formationsagreees-fcc

W. Pharma, Développement Professionnel Continu

. Légifrance, Code de la santé publiquedo;jsessionid=98B29C73FEA439028C0C09A18879 5CB2.tpdjo06v_2? DPC, mode d'emploi. http://www.has-sante.fr/portail/jcms/c_1288606/dpc-mode-d-emploi, FACULTE DE PHARMACIE 1)1"'0;\1& D'&TAT D& DOCTF.UR [." P" ARMAOt